Noseworthy John H 4

What Happened John H. Noseworthy, a director of UnitedHealth Group (UNH), was credited with 52 shares on 2026-03-17 as an award/acquisition. The filing reports the per-share price as $0 and total value as $0 — these shares represent dividend equivalents tied to vested deferred stock units rather than a cash purchase.

Key Details

• Transaction date: 2026-03-17 (Form 4 filed 2026-03-19; filing appears timely).
• Transaction type/code: Award/Acquisition (A).
• Shares received: 52; reported dollar value: $0.
• Shares owned after transaction: not specified in the provided data.
• Footnote: F1 — these are dividend equivalents paid on vested deferred stock units; the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.

Context Dividend-equivalent awards are a form of compensation that credit the recipient with additional shares tied to dividends on deferred stock units. They are not a market purchase (no cash outlay) and are typically part of routine executive/director compensation, not a direct signal of buying or selling intent.